Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here

 

Medical Technology and Device News Title

  • March 26, 2015:

    Apple just announced ResearchKit, a platform for app builders to capture and upload personal medical data. Companies such as Google, Microsoft, and Samsung and hundreds of start-ups are also eyeing the $3 trillion health care industry to disrupt it in the same way Netflix decimated the video-rental industry and Uber is changing transportation.

    These companies plan to use nano-sensors that monitor almost every aspect of our body’s functioning, inside and out. They will be packaged in watches, Band-Aids, clothing, and contact lenses. The data from these will be uploaded into cloud-based platforms such as Apple’s HealthKit. Then, artificial intelligence–based apps will monitor and advise us on what actions/medications we should take to improve our lifestyle and habits.Full Story

  • March 26, 2015:

    Google has secured a patent for a potentially cancer cell-destroying wrist-worn device. The device would make use of functionalized particles in the blood, which are able to selectively bind to targets that often have adverse health effects. Once the targets have been acquired, the wearable device generates energy and sends it to the blood vessels, allowing the targets to be selectively modified or completely destroyed.Full Story

  • March 26, 2015:

    Thanks to a new hand-held instrument developed in the Hansma Lab at UC Santa Barbara called OsteoProbe, doctors are able to measure bone loss according to trial results reported in the Journal of Bone and Mineral Research. OsteoProbe uses reference point indentation (RPI) to measure mechanical properties of bone at the tissue level. This capability is especially useful for people taking glucocorticoids such as prednisone, where bone loss and the increased risk of bone fracture is a well-documented side effect.Full Story

  • March 23, 2015:

    CardioKinetix Inc., announced the three-month clinical and echocardiographic results of a catheter-based treatment for heart failure called PARACHUTE China which studied 31 Chinese patients treated consecutively with the company’s Parachute Ventricular Partitioning Device.
    “The results of this study, which met its primary and secondary endpoints, continue to substantiate the safety profile and effectiveness of the Parachute as a viable minimally invasive ventricular partitioning device for patients with ischemic heart failure,” said Gao Runlin, M.D., chief cardiologist at Fu Wai Hospital, Chinese Academy of Medical Sciences who presented the results at the China Interventional Therapeutics (CIT) 2015 conference in Beijing.Full Story

  • March 18, 2015:

    Ben-Gurion University of the Negev (BGU) researchers has developed a groundbreaking approach to determine sleep quality using their new breath sound analysis (BSA). This is less expensive and invasive than current polysomnography (PSG) technology.
    "We've developed a non-contact 'breathing sound analysis' algorithm that provides a reliable estimation of whole-night sleep evaluation for detection of sleep quality, snoring severity and Obstructive Sleep Apnea (OSA). It has the potential to reduce the cost and management of sleep disorders compared to PSG, the current standard of treatment." says Prof. Yaniv Zigel Ph.D., head of the Biomedical Signal Processing Research Lab in BGU's Department of Biomedical Engineering. Full Story

  • March 10, 2015:

    Born profoundly deaf, Joshua Copen, 5, has learned to talk and hear with the help of cochlear implants. Doctor’s had mistakenly claimed he had normal hearing.  Iara Peng, Joshua’s mother knew better “Noises that should have made him react weren’t.”
    Peng said she owes Joshua’s new lease on life to Kay Chang, MD, a pediatric otolaryngologist and otologic surgeon at Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health, who passionately advocated cochlear implants for Joshua even though cochlear implants were an unconventional approach for a child with Down syndrome.. Full Story

  • March 2, 2015:

    Cardinal Health Inc. agreed to buy Johnson & Johnson’s Cordis business for $1.94 billion in cash, bulking up the medical distributor’s device-making capabilities. Biegelsen, analyst at Wells Fargo in New York indicated the deal is not without risks as there are powerful competitors like Abbott Laboratories.
    The purchase, financed with a combination of $1 billion in new senior unsecured notes and existing cash, will also result in cost savings of more than $100 million annually by the end of fiscal 2018. Cardinal Health expects the proposed deal to add more than 20 cents per share to its fiscal 2017 adjusted earnings. “This is a significant step forward in our cardiovascular strategy,” George Barrett, Cardinal’s chief executive, said in a statement Monday... Full Story